These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26937656)

  • 1. Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
    Saito K; Nakayama E; Valmori D
    PLoS One; 2016; 11(3):e0150623. PubMed ID: 26937656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
    Ohue Y; Eikawa S; Okazaki N; Mizote Y; Isobe M; Uenaka A; Fukuda M; Old LJ; Oka M; Nakayama E
    Int J Cancer; 2012 Sep; 131(5):E649-58. PubMed ID: 22109656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational prediction of vaccine potential epitopes and 3-dimensional structure of XAGE-1b for non-small cell lung cancer immunotherapy.
    Tarek MM; Shafei AE; Ali MA; Mansour MM
    Biomed J; 2018 Apr; 41(2):118-128. PubMed ID: 29866600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro.
    Zhou Q; Guo AL; Xu CR; An SJ; Wang Z; Yang SQ; Wu YL
    Clin Exp Immunol; 2008 Sep; 153(3):392-400. PubMed ID: 18803763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of DR9-restricted XAGE antigen on lung adenocarcinoma recognized by autologous CD4 T-cells.
    Shimono M; Uenaka A; Noguchi Y; Sato S; Okumura H; Nakagawa K; Kiura K; Tanimoto M; Nakayama E
    Int J Oncol; 2007 Apr; 30(4):835-40. PubMed ID: 17332921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
    Talebian Yazdi M; Loof NM; Franken KL; Taube C; Oostendorp J; Hiemstra PS; Welters MJ; van der Burg SH
    Cancer Immunol Immunother; 2015 Sep; 64(9):1109-21. PubMed ID: 26025564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged survival of patients with lung adenocarcinoma expressing XAGE-1b and HLA class I antigens.
    Kikuchi E; Yamazaki K; Nakayama E; Sato S; Uenaka A; Yamada N; Oizumi S; Dosaka-Akita H; Nishimura M
    Cancer Immun; 2008 Aug; 8():13. PubMed ID: 18752338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XAGE-1 expression in non-small cell lung cancer and antibody response in patients.
    Nakagawa K; Noguchi Y; Uenaka A; Sato S; Okumura H; Tanaka M; Shimono M; Ali Eldib AM; Ono T; Ohara N; Yoshino T; Yamashita K; Tsunoda T; Aoe M; Shimizu N; Nakayama E
    Clin Cancer Res; 2005 Aug; 11(15):5496-503. PubMed ID: 16061866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer.
    Pandey JP; Namboodiri AM; Ohue Y; Oka M; Nakayama E
    Clin Exp Immunol; 2014 Apr; 176(1):78-83. PubMed ID: 24304136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma.
    Ali Eldib AM; Ono T; Shimono M; Kaneko M; Nakagawa K; Tanaka R; Noguchi Y; Nakayama E
    Int J Cancer; 2004 Feb; 108(4):558-63. PubMed ID: 14696120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DRB1*0410-restricted recognition of XAGE-1b37-48 peptide by CD4 T cells.
    Morishita Y; Uenaka A; Kaya S; Sato S; Aji T; Nakayama E
    Microbiol Immunol; 2007; 51(8):755-62. PubMed ID: 17704638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of XAGE-1b gene expression with clinical characteristics of non-small cell lung cancer].
    Zhou Q; Guo AL; An SJ; Xu CR; Yang SQ; Wu YL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):966-8. PubMed ID: 17666327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of XAGE-1 isoforms: predominant expression of XAGE-1b in testis and tumors.
    Sato S; Noguchi Y; Ohara N; Uenaka A; Shimono M; Nakagawa K; Koizumi F; Ishida T; Yoshino T; Shiratori Y; Nakayama E
    Cancer Immun; 2007 Mar; 7():5. PubMed ID: 17335148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer.
    Watanabe Y; LePage S; Elliott M; Secrist H; Tanaka T; Kawahara M; Matsumura A; Hosoe S; Ogawara M; Okada M; Repasky B; Sleath P; Wang T; Henderson R
    Cancer Immun; 2006 Feb; 6():3. PubMed ID: 16468707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination.
    Tsuji T; Altorki NK; Ritter G; Old LJ; Gnjatic S
    J Immunol; 2009 Oct; 183(7):4800-8. PubMed ID: 19734225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of overlapping XAGE-1 transcripts encoding a cancer testis antigen expressed in lung, breast, and other types of cancers.
    Egland KA; Kumar V; Duray P; Pastan I
    Mol Cancer Ther; 2002 May; 1(7):441-50. PubMed ID: 12479262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype.
    Palata O; Podzimkova Hradilova N; Mysiková D; Kutna B; Mrazkova H; Lischke R; Spisek R; Adkins I
    Immunol Lett; 2020 Mar; 219():46-53. PubMed ID: 31931024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent T cell responses against immunogenic targets in lung cancer patients for targeted immunotherapy.
    Babiak A; Steinhauser M; Götz M; Herbst C; Döhner H; Greiner J
    Oncol Rep; 2014 Jan; 31(1):384-90. PubMed ID: 24154794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
    Iversen TZ
    Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice.
    Saif JM; Vadakekolathu J; Rane SS; McDonald D; Ahmad M; Mathieu M; Pockley AG; Durrant L; Metheringham R; Rees RC; McArdle SE
    Eur J Immunol; 2014 Apr; 44(4):994-1004. PubMed ID: 24338683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.